Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ADZINC
- Development stage
- Unknown
- Lead developer
- Adwin Life Care
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
ADZINC is a zinc-based nutritional supplement and pharmaceutical preparation developed and marketed by Adwin Life Care. Available in both tablet and syrup formulations, it is primarily indicated for the clinical management of acute and persistent diarrhea, particularly in pediatric populations, and for the treatment of zinc deficiency. As an essential trace element, zinc plays a fundamental role in immune function, protein synthesis, and cellular metabolism. In the gastrointestinal tract, zinc supplementation helps restore mucosal integrity and enhances the absorption of water and electrolytes, which effectively reduces the severity and duration of diarrheal episodes.
- Brand names
- ADZINC
Beyond the preview
Go deeper on ADZINC.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ADZINC.